Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Monday, March 8, 1999 Published at 14:40 GMT


Sci/Tech

Cancer stung by new research

Honey bees (apis mellifera)

By BBC News Online Science Editor Dr David Whitehouse

Australian scientists are modifying bee venom to develop cancer treatments that may have fewer side effects than other drugs used to fight the disease.

A research project to utilise an active ingredient from bee venom as a potential cure for cancer has just been funded.


[ image: Part of the mellitin molecule]
Part of the mellitin molecule
The venom in the bee sting contains a number of active ingredients, the main one being mellitin, a molecule that kills cells by slicing through cell walls.

"What we have done is to modify the structure of the mellitin molecule and remove the part that causes the allergic reaction while still maintaining its ability to kill cells," said Dr Jerome Werkmeister of the Commonwealth Science and Industry Research Organisation, CSIRO.

One problem the researchers have to tackle is targeting the cell-killing activity of mellitin to cancer cells only and not to normal healthy cells.

Antibody molecule

They plan to achieve this by attaching the modified mellitin to an antibody molecule that specifically recognises cancer cells. The combination of a toxin and an antibody is called an immunotoxin.

"Chemotherapy drugs are not specific; they attack normal cells thereby causing unwanted side effects such as hair loss, vomiting and weight loss.

"Such symptoms limit the amount of drug that can be administered and hence its effectiveness," says CSIRO's Dr Dean Hewish.

Dr Werkmeister points out that mellitin is far less toxic than the plant and bacterial toxins used in earlier work. New immunotoxin drugs produced from it may reduce potential side effects while still retaining the specific killing of target cancers.

"We still have a fairly long way to go with this research. We are still some time from clinical application, but we are very optimistic," Dr Werkmeister concludes.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Sci/Tech Contents


Relevant Stories

27 Feb 99 | Health
Cold cure for cancer

04 Nov 98 | Health
Arsenic beats cancer

06 Oct 98 | Health
Growing cancer cells the space-age way





In this section

World's smallest transistor

Scientists join forces to study Arctic ozone

Mathematicians crack big puzzle

From Business
The growing threat of internet fraud

Who watches the pilots?

From Health
Cold 'cure' comes one step closer